Edit |   |
---|---|
Antigenic Specificity | CD262, Human (Conatumumab biosimilar) |
Clone | Conatumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD262 Recombinant Antibody (Conatumumab). Conatumumab (originally AMG-655) is a monoclonal antibody developed for the treatment of cancer. It is a fully human monoclonal agonist antibody directed against the extracellular domain of human TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptor 2 (TR-2, death receptor 5) with potential antineoplastic activity. |
Immunogen | n/a |
Other Names | Anti-CD262 Recombinant Antibody, Research Grade Conatumumab, Anti-Human CD262 Recombinant Antibody(Conatumumab), AMG 655, TRAIL-R2mAb, XG1-048vw, Antibody Drug Analogues, Monoclonal Antibody, YR1142, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 896731-82-1 |
Catalog # | YR1142 |
Price | please inquire |
Order / More Info | CD262, Human (Conatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |